|
C1ORF156 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.158000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.793600E-01 |
| Normal-vs-Stage2 |
1.813180E-01 |
| Normal-vs-Stage3 |
4.141800E-01 |
| Normal-vs-Stage4 |
8.624400E-01 |
| Stage1-vs-Stage2 |
1.378570E-01 |
| Stage1-vs-Stage3 |
2.914600E-01 |
| Stage1-vs-Stage4 |
8.256200E-01 |
| Stage2-vs-Stage3 |
5.417900E-02 |
| Stage2-vs-Stage4 |
1.905600E-01 |
| Stage3-vs-Stage4 |
6.151000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.784600E-01 |
| Normal-vs-AfricanAmerican |
4.502800E-01 |
| Normal-vs-Asian |
3.640200E-02 |
| Caucasian-vs-AfricanAmerican |
3.699000E-01 |
| Caucasian-vs-Asian |
2.607600E-02 |
| AfricanAmerican-vs-Asian |
5.099000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.771400E-01 |
| Normal-vs-Female |
8.365600E-01 |
| Male-vs-Female |
6.686000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.521800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.947400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.715400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.506000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.168200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.950800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.648800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.163400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.307600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.332200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.539400E-01 |
| Classical-VS-Follicular |
5.73110003898591E-09 |
| Classical-VS-Other |
2.712800E-01 |
| Classical-VS-Normal |
1.194590E-01 |
| Tall-VS-Follicular |
3.043900E-03 |
| Tall-VS-Other |
4.011200E-01 |
| Tall-VS-Normal |
4.749000E-01 |
| Follicular-VS-Other |
4.489400E-01 |
| Follicular-VS-Normal |
1.635960E-03 |
| Other-VS-Normal |
6.808800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.434200E-01 |
| Normal-vs-N1 |
7.060200E-01 |
| N0-vs-N1 |
9.488000E-01 |
|
|
